Jiangxi Sanxin Medtec Co.,Ltd. (300453.SZ)
CNY 7.99
(-0.37%)
CNY 7.99
(-0.37%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 257.64 Million CNY | -1.8% |
| 2022 | 230.01 Million CNY | 17.94% |
| 2021 | 195.03 Million CNY | 25.69% |
| 2020 | 155.17 Million CNY | 100.18% |
| 2019 | 77.51 Million CNY | 61.57% |
| 2018 | 47.97 Million CNY | -2.18% |
| 2017 | 49.04 Million CNY | 12.71% |
| 2016 | 43.51 Million CNY | -16.78% |
| 2015 | 52.29 Million CNY | 0.42% |
| 2014 | 52.07 Million CNY | -2.7% |
| 2013 | 53.51 Million CNY | 6.1% |
| 2012 | 50.43 Million CNY | 31.79% |
| 2011 | 38.26 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 73.82 Million CNY | 20.94% |
| 2024 Q2 | 61.04 Million CNY | 8.79% |
| 2024 Q1 | 56.11 Million CNY | -16.15% |
| 2023 Q1 | 54.79 Million CNY | 12.67% |
| 2023 Q2 | 54.08 Million CNY | -1.29% |
| 2023 FY | 225.88 Million CNY | -1.8% |
| 2023 Q4 | 66.92 Million CNY | 7.19% |
| 2023 Q3 | 62.43 Million CNY | 15.45% |
| 2022 FY | 230.01 Million CNY | 17.94% |
| 2022 Q4 | 48.63 Million CNY | -0.86% |
| 2022 Q3 | 49.05 Million CNY | -32.7% |
| 2022 Q2 | 72.89 Million CNY | 22.63% |
| 2022 Q1 | 59.43 Million CNY | 31.87% |
| 2021 Q2 | 47.74 Million CNY | 8.62% |
| 2021 Q3 | 58.26 Million CNY | 22.04% |
| 2021 FY | 195.03 Million CNY | 25.69% |
| 2021 Q1 | 43.95 Million CNY | 0.07% |
| 2021 Q4 | 45.07 Million CNY | -22.64% |
| 2020 Q3 | 46.46 Million CNY | 0.43% |
| 2020 Q2 | 46.26 Million CNY | 149.76% |
| 2020 Q1 | 18.52 Million CNY | -33.86% |
| 2020 FY | 155.17 Million CNY | 100.18% |
| 2020 Q4 | 43.92 Million CNY | -5.47% |
| 2019 Q1 | 5.89 Million CNY | -58.31% |
| 2019 FY | 77.51 Million CNY | 61.57% |
| 2019 Q4 | 28 Million CNY | -5.94% |
| 2019 Q3 | 29.77 Million CNY | 115.07% |
| 2019 Q2 | 13.84 Million CNY | 134.9% |
| 2018 Q4 | 14.13 Million CNY | -5.01% |
| 2018 FY | 47.97 Million CNY | -2.18% |
| 2018 Q3 | 14.88 Million CNY | 38.14% |
| 2018 Q2 | 10.77 Million CNY | 31.54% |
| 2018 Q1 | 8.18 Million CNY | -39.38% |
| 2017 Q1 | 7.05 Million CNY | -40.65% |
| 2017 FY | 49.04 Million CNY | 12.71% |
| 2017 Q4 | 13.5 Million CNY | -1.18% |
| 2017 Q3 | 13.66 Million CNY | -7.76% |
| 2017 Q2 | 14.81 Million CNY | 110.15% |
| 2016 Q1 | 9.05 Million CNY | -36.5% |
| 2016 Q4 | 11.88 Million CNY | 0.99% |
| 2016 FY | 43.51 Million CNY | -16.78% |
| 2016 Q2 | 10.82 Million CNY | 19.55% |
| 2016 Q3 | 11.76 Million CNY | 8.7% |
| 2015 FY | 52.29 Million CNY | 0.42% |
| 2015 Q1 | 10.01 Million CNY | -31.45% |
| 2015 Q4 | 14.25 Million CNY | 17.63% |
| 2015 Q3 | 12.11 Million CNY | -23.82% |
| 2015 Q2 | 15.9 Million CNY | 58.91% |
| 2014 Q1 | 9.63 Million CNY | 0.0% |
| 2014 FY | 52.07 Million CNY | -2.7% |
| 2014 Q2 | 14.98 Million CNY | 55.54% |
| 2014 Q3 | 12.84 Million CNY | -14.27% |
| 2014 Q4 | 14.6 Million CNY | 13.66% |
| 2013 FY | 53.51 Million CNY | 6.1% |
| 2012 FY | 50.43 Million CNY | 31.79% |
| 2011 FY | 38.26 Million CNY | 0.0% |